Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells.

De Novo and Rare Variants at Multiple Loci Support the Oligogenic Origins of Atrioventricular Septal Heart Defects. PLoS Genet (2016) 0.87

Wnt/β-catenin signaling enables developmental transitions during valvulogenesis. Development (2016) 0.86

Valve Endothelial Cell-Derived Tgfβ1 Signaling Promotes Nuclear Localization of Sox9 in Interstitial Cells Associated With Attenuated Calcification. Arterioscler Thromb Vasc Biol (2015) 0.79

Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves. Arterioscler Thromb Vasc Biol (2016) 0.79

Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification. Arterioscler Thromb Vasc Biol (2016) 0.77

Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology. J Am Heart Assoc (2015) 0.77

Genetic tools for identifying and manipulating fibroblasts in the mouse. Differentiation (2016) 0.75

Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease. Cardiovasc Res (2016) 0.75

Increased canonical WNT/β-catenin signalling and myxomatous valve disease. Cardiovasc Res (2017) 0.75

Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2003) 12.94

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature (2009) 9.15

Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development (2001) 9.00

Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol (2002) 8.60

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell (2005) 8.16

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell (2005) 6.90

Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev (2004) 4.78

Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev (2008) 4.38

Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol (2006) 2.95

The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature (2003) 2.89

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation (2011) 2.73

Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol (2004) 2.57

Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res (2008) 2.44

Heart valve development: regulatory networks in development and disease. Circ Res (2009) 2.41

Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation (2006) 2.41

Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev Cell (2012) 2.28

Mitral valve prolapse. Lancet (2005) 1.99

Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet (2008) 1.90

New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation (2005) 1.87

Heart valve structure and function in development and disease. Annu Rev Physiol (2011) 1.80

Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol (2007) 1.67

Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol (2006) 1.65

RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J Biol Chem (2005) 1.64

BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol (2006) 1.46

The role of TGFbetas and Sox9 during limb chondrogenesis. Curr Opin Cell Biol (2006) 1.41

Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev Biol (2007) 1.35

Unraveling the transcriptional regulatory machinery in chondrogenesis. J Bone Miner Metab (2011) 1.34

Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development (2011) 1.30

Reduced sox9 function promotes heart valve calcification phenotypes in vivo. Circ Res (2010) 1.30

The transcriptional activity of Sox9 in chondrocytes is regulated by RhoA signaling and actin polymerization. Mol Cell Biol (2009) 1.27

SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J Biol Chem (2004) 1.27

Wnt signaling in heart valve development and osteogenic gene induction. Dev Biol (2009) 1.22

SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet (2011) 1.16

Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation. J Cell Physiol (2012) 1.13

Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J Mol Cell Cardiol (2010) 1.12

Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. Biochem Biophys Res Commun (2008) 1.07

Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. Dev Biol (2010) 1.06

Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes. PLoS One (2011) 0.95

The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease. Cardiovasc Pathol (2010) 0.93

Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease. J Mol Cell Cardiol (2012) 0.90

Mitral valve prolapse. Annu Rev Med (2012) 0.88

Comparison of the biological response of osteoblasts after tension and compression. Eur J Orthod (2011) 0.87

The chondrocytic journey in endochondral bone growth and skeletal dysplasia. Birth Defects Res C Embryo Today (2014) 0.87

Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data. Cardiovasc Pathol (2012) 0.84

Signaling pathways in mitral valve degeneration. J Vet Cardiol (2012) 0.82

Mef2c regulates transcription of the extracellular matrix protein cartilage link protein 1 in the developing murine heart. PLoS One (2013) 0.81

Genetic basis of familial valvular heart disease. Circ Cardiovasc Genet (2012) 0.78